Announcements Trials
Browse Landscape

Phase

Phase 2 5Phase 1 1

Status

Unknown 9Recruiting 9Not yet recruiting 6Terminated 3Completed 3Active not recruiting 3Withdrawn 1

Sponsor Class

OTHER 5OTHER_GOV 1

Study Type

Interventional 6Observational 1

Sponsor

Cancer Type

Gastrointestinal 6

Conditions

Breast Neoplasms 424Neoplasms 281Carcinoma, Non-Small-Cell Lung 272Colorectal Neoplasms 236Prostatic Neoplasms 173Lung Neoplasms 172Carcinoma, Hepatocellular 157Stomach Neoplasms 126Leukemia, Myeloid, Acute 120Pancreatic Neoplasms 118Multiple Myeloma 106Recurrence 99Uterine Cervical Neoplasms 97Squamous Cell Carcinoma of Head and Neck 89Neoplasm Metastasis 88Rectal Neoplasms 87Ovarian Neoplasms 81Triple Negative Breast Neoplasms 77Small Cell Lung Carcinoma 72Head and Neck Neoplasms 69Brain Neoplasms 68Esophageal Neoplasms 65Glioblastoma 64Endometrial Neoplasms 60Colonic Neoplasms 59Melanoma 55Hematologic Neoplasms 53Precursor Cell Lymphoblastic Leukemia-Lymphoma 48Motor Activity 48Carcinoma, Renal Cell 47

Interventions

apatinib 2disitamab vedotin 1SHR-1701 1S 1 (combination) 1Oxaliplatin 1Indocyanine Green 1Gastrectomy 1130-nm albumin-bound paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Not yet recruiting × Interventional × Gastric Adenocarcinoma × Clear all
NCT07621562 2026-06-02

Tafolecimab Combined With Sintilimab and SOX in the Treatment of pMMR/MSS Gastric Cancer

First Affiliated Hospital of Zhejiang University

Phase 2 Not yet recruiting
30 enrolled
Gastrointestinal

Gastric Adenocarcinoma

NCT07610629 2026-05-28

RA-A-NP

Henan Cancer Hospital

Phase 2 Not yet recruiting
50 enrolled
Gastrointestinal

Gastric Adenocarcinoma

NCT07507526 2026-04-02

DTP-HER2

Sun Yat-sen University

Phase 2 Not yet recruiting
76 enrolled
Gastrointestinal

Gastric Adenocarcinoma

NCT07464756 2026-03-11

SHR-1701 With or Without Apatinib in Combination With Chemotherapy as Neoadjuvant Therapy for Gastric Cancer

The First Affiliated Hospital with Nanjing Medical University

Phase 2 Not yet recruiting
80 enrolled
Gastrointestinal

Gastric Adenocarcinoma

NCT05038098 2026-03-05

Magnetic Sentinel Lymph Node Mapping in Gastric Cancer

M.D. Anderson Cancer Center

Phase 1 Not yet recruiting
20 enrolled
Gastrointestinal

Gastric Adenocarcinoma

NCT06888037 2025-03-21

Fruquintinib Combined With PD-1 Inhibitor as First-line Maintenance Therapy for Advanced Gastric Cancer

Ruijin Hospital

Phase 2 Not yet recruiting
55 enrolled
Gastrointestinal

Gastric Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡